A Career as a Professional Homeopath Is a Fulfilling Choice

Homeopaths help patients in a deep and long lasting way. It is a very fulfilling career. Here, Sarah Hemsley, a homeopath for over 25 years describes her training and career choice.

Advertisements

Leading Scientist and Chemist Becomes Professional Homeopath

One of the leading research chemists and scientists was so impressed with homeopathy that he decided to study it and is now a practising homeopath. Dr Lionel R Milgrom BSc, MSc, PhD, CChem, FRSC, LCH, MARH, RHom. is a Fellow of the Royal Society of Chemistry and his research and articles are highly cited in leading science journals. He has practised for a number of years as a professional homeopath in London, England.

Apart from homeopathy, I have also been a research chemist for over 30 years, holding several science degrees, including a doctorate in chemistry. I am a Chartered Chemist, and a Fellow of the Royal Society of Chemistry. My chemistry research over the past 12 years has concentrated on the use of light and biologically-targeted pigments as a novel treatment for cancer. In 2001, this culminated in the formation of a university spin-out company to propagate and commercialise this research. I am also a science journalist, writing about chemistry and CAM (Complimentary and Alternative Medicine) for many leading newspapers, journals and magazines. – www.lionelmilgrom.com

British ASA Skeptics “Defame” Swiss Government Experts in Attempt to Squelch Homeopathy

The Swiss Health Technology Assessment (HTA) was founded in 1999 for the scientific evaluation of medical technologies on the basis of their effectiveness, appropriateness, and efficiency, as well as social and ethical aspects and implications. All government agencies, all University Institutes, several University Hospitals dealing with Technology Assessment and the Swiss Medical Association are members and give input on any therapy being considered. A number of years ago, the Swiss used precise scientific information and this input to come to the conclusion that homeopathy should be integrated into the Swiss National Health system and paid for under the Swiss government medical system. They generated an authoritative report that was remarkable in its rigorous thoroughness and scientific comprehensiveness.

The British Advertising Authority, (ASA) which is a private a company, in a process of evaluating advertising by homeopathic practitioners rejected this HTA report outright. The professors of medicine who wrote the Swiss government report on homeopathy have complained that the authors of the British Advertising Authority report either did not bother to read their report or “bizarrely” stated falsehoods about it. The professors claim they have been “defamed” and that the ASA report is false. The Swiss Researchers and professors say the ASA report as well as subsequent handling of complaints by the ASA was thoroughly unprofessional and misleading.

The Swiss professors of medicine wrote to the British ASA:

“In conclusion, we state that your writing does not even begin to approach a professional standard. We take great exception to your untenable allegation that we researched this important subject with the superficiality that you suggest, an implication that we consider defamatory. You accuse us of basing our conclusions largely on a reworking of one deeply flawed paper, the Shang study. Yet this is the one paper on which you appear to have based your own conclusions, which are flatly contradicted by swathes of contrary evidence of which you revealingly make no mention. We find this bizarre.

It is customary that authors whose work is misrepresented should have the right of a reply to be published in the same location as the attack was published. We therefore demand that you please place our reply on your website, with equal prominence to your own text.”…

“Aside from a legal incumbency to present facts truthfully and to correct errors made, I hope we can agree as a question of basic morality that members of the public should not be subjected to false or misleading communications – including yours.”

The ASA representatives brushed off the complaints in a perfunctory manner and have refused to publish any of the positive Swiss government conclusions on homeopathy written by unbiased Swiss scientific experts.

More…

New Study Shows Homeopathy Treatment After Tuberculosis Significantly Improves Lung Capacity and Breathing

A new study has shown that homeopathy is effective in improving lung capacity, cough, breathing and general health  in patients who had previously undergone conventional treatment for tuberculosis. It was a double blind study and the results were remarkable.

The conclusion was that “Homeopathy is effective in improving lung capacity and health status. Benefits remain evident after a year. This suggests that homeopathy could make an important contribution to post treatment tuberculosis pulmonary impairment.”

Purpose
Previous studies show that treated and cured pulmonary tuberculosis patients do suffer from pulmonary impairment, lower health related quality of life, disability and long term morbidity, thus responsible for a majority of the disease burden. Despite this, no effective management is available for most of the patients. Therefore, the present study was undertaken to evaluate the impact of homeopathy on pulmonary, functional and quality of life status of patients with pulmonary tuberculosis who have completed treatment.
Methods
Patients who were cured and had completed anti-tuberculosis treatment within a period of 5 years were enrolled in a randomized double-blind placebo-controlled trial. Individualised homeopathy treatment was given to 61 patients and identical placebo to 57 patients. Symptomatic changes, pulmonary function tests, and health related quality of life were assessed prior to treatment, after 6 months of intervention, and followed up for a year after completing the intervention.
Results
Significant improvement was observed with the homeopathy treatment in FEV1 (p<0.001), forced vital capacity (p<0.001), and FEV1/FVC ratio (p=0.002). Symptom scores for cough and breathlessness were significantly lower with homeopathy than with placebo (p<0.001). At the end of treatment, patients on homeopathy had increased body weight (p<0.0001), and better quality of life (p<0.05) compared with placebo (p=0.003). Benefits were maintained in the homeopathy group after a year whereas symptoms (p<0.01) and impact score (p<0.001) deteriorated in placebo. Physicians visits were reduced in the homeopathy group by 58.0% (p =0.002) compared to placebo (p<0.0001).
Conclusion
Homeopathy is effective in improving lung capacity and health status. Benefits remain evident after a year. This suggests that homeopathy could make an important contribution to post treatment tuberculosis pulmonary impairment.

-Biomed Central

Overlooked Study Demonstrated Improvement From Homeopathic Treatment Can Last For Many Years

A Long Term Observational Study of 3,709 patients In Germany concluded that “Patients who seek homeopathic treatment are likely to improve considerably. These effects persist for as long as 8 years.”

The study published in 2008 showed that homeopathy in general can help individuals with multiple chronic problems and that the effect can last for many years. The study was a complex one and much was done to maintain statistical integrity.

In total 2,722 (1,903 adults, 819 children) contributed data to the 8-years follow-up. Patients in this study suffered from long-term chronic diseases (table 1). Response rates were considerable higher in female than in male adults (74.3% vs. 67.2%) but similar in female and male children (76.9% vs. 75.7%). Thus, male adults are somewhat a bit underrepresented in our sample. Age at study entry matched the data of the complete sample (table 1).

Table 1. Patient characteristics (values are absolute numbers and percent or mean ± standard deviation)
The majority of the patients were highly educated female adults, most of them fairly below the age of 60 (table 1). Adults mainly suffered from headache (tension type and migraine), allergic diseases, or skin diseases, children from atopic eczema or multiple infections. The average number of diseases at baseline was 2.8 ± 1.1 in adults and 2.3 ± 1.0 in children.

During the study mean severity of complaints improved from baseline 6.2 ± 1.7 to 2.7 ± 2.1 after 8 years in adults and from 6.1 ± 1.8 to 1.7 ± 1.9 in children (table 3, figure 1). From the generalised linear model the respective standardised mean changes (mean changes divided by standard deviations at baseline) were estimated at 1.61 for adults (CI: 1.54 to 2.68, p < 0.001) and 2.01 for children (CI: 1.89 to 2.12, p < 0.001).

1283 adults (67.4% of the study population, 48.7% of all responders) and 655 children (80.0%/61.0%) experienced a clinically relevant treatment success, defined as an improvement of complaint severity of 2 pts or more. From the logistic regression we found that this was more likely in women than in men, and in children than in adults. Patients who simultaneously used other treatments (conventional or complementary) had a smaller chance to improve relevantly, as did those suffering from allergies, allergic rhinitis, or headache. In contrast, a diagnosis of multiple infections was a positive predictor (table 6).

See the Article in Biomed Central entitled: “How healthy are chronically ill patients after eight years of homeopathic treatment? – Results from a long term observational study”

Homeopathy Effective for Childhood Migraines

A new study has demonstrated homeopathy’s effectiveness in treating childhood migraines. Homeopathy has traditionally been very effective in the treatment of migraine headaches suffered by patients of all ages. The  new observational and nonrandomized multicenter study of 59 physicians in 12 countries used primarily homeopathic remedies treating children with migraine headaches.

The results of this study demonstrate the interest of homeopathic medicines for the prevention and treatment of migraine attacks in children. A significant decrease in the frequency, severity, and duration of migraine attacks was observed and, consequently, reduced absenteeism from school.

The full study was published in The Journal of Alternative and Complementary Medicine, February 2013. Here’s more information:

Outcome measures: The frequency, intensity, and duration of migraine attacks in the 3 months prior to inclusion were compared with those during the 3-month follow-up period. Pertinent data were collected using questionnaires completed by the doctor and the patient or his/her parent/guardian. The secondary outcome measure was the impact of homeopathic medicines on education, measured as absence from school.

Results: The frequency, severity, and duration of migraine attacks decreased significantly during the 3-month follow-up period (all p<0.001). Preventive treatment during this time consisted of homeopathic medicines in 98% of cases (mean=2.6 medicines/patient). Children spent significantly less time off school during follow-up than before inclusion (2.0 versus 5.5 days, respectively; p<0.001). The most common preventive medicines used were Ignatia amara (25%; mainly 9C), Lycopodium clavatum (22%), Natrum muriaticum (21%), Gelsemium (20%), and Pulsatilla (12%; mainly 15C). Homeopathy alone was used for the treatment of migraine attacks in 38% of cases. The most commonly used medicines were Belladonna (32%; mainly 9C), Ignatia amara (11%; mainly 15C), Iris versicolor (10%; mainly 9C), Kalium phosphoricum (10%; mainly 9C), and Gelsemium (9%; mainly 15C and 30C).

Official Swiss Government Study and Report Dramatically Affirms Homeopathy’s Positive Results, Safety and Cost Effectiveness

A new study and report by the Swiss Government has been published in an English book form.  It is the most comprehensive study of homeopathy undertaken  by a government.  As reported on Huffington Post the report is the most significant and largest study of homeopathy ever undertaken.

“The Health Technology Assessment report on effectiveness, cost-effectiveness and appropriateness of homeopathy was compiled on behalf of the Swiss Federal Office for Public Health (BAG) within the framework of the ‘Program of Evaluation of Complementary Medicine (PEK)”.

After carefully monitoring homeopathic treatment in Switzerland and also taking an extensive overview of all scientific studies of homeopathy it concludes that “taking internal and external validity criteria into account, effectiveness of homeopathy can be supported by clinical evidence and professional and adequate application be regarded as safe”(PubMed).  They concluded that homeopathic treatment should continued to be reimbursed by Switzerland’s national health insurance program.

“The Swiss government’s “Health Technology Assessment” on homeopathic medicine is much more comprehensive than any previous governmental report written on this subject to date. Not only did this report carefully and comprehensively review the body of evidence from randomized double-blind and placebo controlled clinical trials testing homeopathic medicines, they also evaluated the “real world effectiveness” as well as safety and cost-effectiveness. The report also conducted a highly-comprehensive review of the wide body of preclinical research (fundamental physio-chemical research, botanical studies, animal studies, and in vitro studies with human cells).

And still further, this report evaluated systematic reviews and meta-analyses, outcome studies, and epidemiological research. This wide review carefully evaluated the studies conducted, both in terms of quality of design and execution (called “internal validity”) and how appropriate each was for the way that homeopathy is commonly practiced (called “external validity”).

After assessing pre-clinical basic research and the high quality clinical studies, the Swiss report affirmed that homeopathic high-potencies seem to induce regulatory effects (e.g., balancing or normalizing effects) and specific changes in cells or living organisms. The report also reported that 20 of the 22 systematic reviews of clinical research testing homeopathic medicines detected at least a trend in favor of homeopathy.* (Bornhöft, Wolf, von Ammon, et al, 2006)

The Swiss report noted that the Shang team [who authored the Lancet meta-analysis] did not even adhere to the QUORUM guidelines which are widely recognized standards for scientific reporting (Linde, Jonas, 2005).

Dana Ullman MPH on Huffington Post